Navigation Links
Watson to Present at the 2011 Piper Jaffray Health Care Conference
Date:11/21/2011

PARSIPPANY, N.J., Nov. 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2011 Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at 9:30 am EST at the New York Palace Hotel in New York. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL:

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=WPI&item_id=4229079

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors: 

Patty Eisenhaur 

(862) 261-8141 

  Media: 

Charlie Mayr 

(862) 261-8030

 
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Watson Wins Kentucky Drug Pricing Litigation
2. Watson Confirms Exelon(R) Patent Challenge
3. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
4. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
5. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
6. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
7. Watson Confirms Daytrana(R) Patent Challenge
8. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
9. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
10. Watson Confirms EMBEDA(R) Patent Challenge
11. Watson Launches Generic FEMCON(R) Fe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- The number of people overdosing from opioid prescription ... percent of the workforce has misused prescription painkillers, according ... making opioid use a serious threat to employee safety. ... correct dosage with a valid prescription, subtle impairment may ... Safety Council released a guide for employers, ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... -- Elekta (NSE:EKTAb) and Royal Philips (NYSE: ... Trust ( Manchester, UK ), a specialist ... to develop the clinical value of an integrated magnetic ... system would, in principle, improve the practice of radiotherapy ... "The Christie was an essential participant in the project ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... Lilly and Company (NYSE: LLY ) announced ... Lilly to access innovation being developed outside the company,s ... independent venture capital firms participating in the Mirror Portfolio ... stage of their development. The first is a molecule ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... launched Voriconazole Tablets, 50 mg and 200 mg, under ... Inc. Mylan was the first company to have filed ... for Voriconazole Tablets and was awarded 180 days of ...
Cached Medicine Technology:Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 2Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 3Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 4
(Date:7/22/2014)... 2014 Two individuals from Meditec, a ... Association for Healthcare Documentation Integrity (AHDI) Awards. One nominee ... the sole nominee for both the Excellence in Credentialing ... Linda Curia, is also nominated for the Rising Star ... field for over 18 years in a wide-variety of ...
(Date:7/22/2014)... NY (PRWEB) July 22, 2014 As ... Icahn School of Medicine at Mount Sinai have helped ... with the risk of developing schizophrenia, in the largest ... conducted with 80,000 people. The findings, published online in ... underlie schizophrenia, and could lead to new approaches to ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 University ... officially opened the doors of its state-of-the-art, $151 ... in the heart of downtown San Francisco's South of ... 10,000 patients a year. Those patients will now be ... sophisticated iKiosks . , Advanced Kiosks engineering ...
(Date:7/22/2014)... 22, 2014 (HealthDay News) -- Genetic fragments of the deadly ... where an infected camel was kept, a new study says. ... determine if Middle East Respiratory Syndrome (MERS) can be transmitted ... samples over three consecutive days from a camel barn owned ... the town of Jeddah, Saudi Arabia. The man later died. ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
Breaking Medicine News(10 mins):Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 2Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2
... pleased to announce the appointment of Dr. Elisa J. Zinberg as ... effective immediately. , ... Rye, NY (PRWEB) September 23, ... Elisa J. Zinberg as Vice - President of Operations, and member ...
... The ALS Association,s comprehensive Assistive Technology Consultation Program. The program ... ALS, also known as Lou Gehrig,s Disease, and training on available ... at the Associaton,s Chapters and Certified Centers of Excellence. , ... ...
... Coinstar Centers(R) at retail locations,nationwide, WASHINGTON, Sept. 22 ... to those affected by the recent,hurricanes by donating their ... retail locations. Simply select the Red Cross Disaster Relief ... Cross to provide immediate,food, shelter, counseling and other assistance ...
... Reasons for slowed time to treatment remain unclear, experts say ... including those on Medicaid, are more likely to take much ... strikes compared to more affluent people, a new study finds. ... at a greater risk of missing a critical window for ...
... SACRAMENTO, Calif., Sept. 22 The California Office of,Traffic Safety ... riding in car safety seats. The 2008 rate of 94.4 ... a big jump of 6.7,percentage points over the 2007 rate ... time to kick off the national Child,Passenger Safety Week, September ...
... model, it appears that comparing the benefits and risks ... and their physicians choose appropriate screening strategies, according to ... Archives of Internal Medicine , one of the JAMA/Archives ... known as Pap smears, is credited with reducing the ...
Cached Medicine News:Health News:Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 3Health News:Americans Urged to Support American Red Cross Disaster Relief Efforts for Hurricanes of 2008 2Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Record Upsurge in State's Child Safety Seat Usage Marks Child Passenger Safety Week 2Health News:Model highlights benefits and risks of cervical cancer screening methods 2
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
96-Well PCR Plate Sealing Mat...
Inquire...
Inquire...
Medicine Products: